middle.news
Neurizon Raises A$2.7M to Support NUZ-001 Clinical and Commercial Plans
9:38am on Thursday 16th of April, 2026 AEST
•
Healthcare
Read Story
Neurizon Raises A$2.7M to Support NUZ-001 Clinical and Commercial Plans
9:38am on Thursday 16th of April, 2026 AEST
Key Points
Placement of entitlement offer shortfall raises A$2.7 million
Total funds raised under entitlement offer now about A$8.5 million
Funds to support Phase 2/3 trial and commercialisation of NUZ-001
Potential to reduce reliance on convertible note facility drawdown
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neurizon Therapeutics (ASX:NUZ)
OPEN ARTICLE